Browsing: Therapeutics

Drew Angerer/Getty Photos Information Bristol-Myers Squibb (NYSE:BMY) agreed to buy most cancers drug maker Mirati Therapeutics (NASDAQ:MRTX) for about $4.8…

Meletios Verras At a Look Revisiting Poseida Therapeutics (NASDAQ:PSTX), the corporate continues to intrigue with its diversified cell and gene…

JHVEPhoto/iStock Editorial through Getty Photographs Replace 2:50pm: Updates shares, provides authorized knowledgeable remark. Corcept Therapeutics (NASDAQ:CORT) plummeted 17% amid a…

nicolas_ Construction Therapeutics (NASDAQ:GPCR) climbed ~67% pre-market after the clinical-stage biotech mentioned that its oral GLP-1 receptor agonist GSBR-1290 generated…